Search - tctmd.com

Displaying 681 - 700 of 7811

Sort: Relevancy | Date

News Daily News

Large Meta-analysis Supports Radial as Default Approach in All CAD Types

L.A. McKeown

July 06, 2016

News Daily News

Increased Consumption of Subsidized Foods Ups Cardiometabolic Risk

Leah Lawrence

July 06, 2016

News Industry News

Arizona patient will receive first U.S.-approved fully dissolving heart stent

July 06, 2016

News Daily News

欧盟更快速核准医疗器械导致更多的安全警告和产品召回

Shelley Wood

July 05, 2016

News Daily News

Timing and Type of Events Post-PCI Have Implications for Prognosis—and Honest Discussions With Patients

Yael L. Maxwell

July 05, 2016

News Daily News

TAVR 可用于治疗二尖瓣主动脉瓣狭窄，但与永久性起搏器植入率更高相关联

Michael O'Riordan

July 05, 2016

News Daily News

TAVR for Bicuspid Aortic Valve Stenosis Feasible, but Associated With Higher Rate of Permanent Pacemaker Implantation

Michael O'Riordan

July 05, 2016

News Daily News

Structured Exercise Program Can Help the Sedentary Elderly but Does Not Curb CV Events

Michael H. Wilson

July 05, 2016

News Daily News

Now You See It: FDA Approves Absorb Bioresorbable Scaffold

Michael O'Riordan

July 05, 2016

News Daily News

Medical Devices Approved More Quickly in EU Face More Safety Alerts and Recalls

Shelley Wood

July 05, 2016

News Daily News

Los Dispositivos Médicos Aprobados Más Rápidamente en la UE son Objeto de Más Alertas de Seguridad y Nuevas Inspecciones

Shelley Wood

July 05, 2016

News Daily News

La Intervención TAVR para el Manejo de la Estenosis de la Válvula Aórtica Bicúspide es Viable pero se asocia a un Índice Más Alto de Implantación de Marcapasos Permanente

Michael O'Riordan

July 05, 2016

News Opinion Fellow Talk

Fellowships in Advanced Interventional and Structural Cardiology Need Structure, Planning, and Collaboration—Stat!

Ankur Kalra

July 05, 2016

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2016

Shelley Wood

July 01, 2016

News Daily News

Un Panel Asesor de la FDA Recomienda por un Estrecho Margen una Indicación de Mortalidad por EAC para el Antidiabético Empagliflozina

Michael O'Riordan

June 30, 2016

News Daily News

Precious Time: Questionable Treatments Often Used at the End of Life

Todd Neale

June 30, 2016

News Daily News

FDA 顾问小组小范围建议使用糖尿病药物 empagliflozin 来改善 CVD 死亡率

Michael O'Riordan

June 30, 2016

News Daily News

FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin

Michael O'Riordan

June 30, 2016

News Daily News

Deadly Deceleration? Annual Declines in US Cardiovascular Death Rate Start to Slow

Caitlin E. Cox

June 30, 2016

News Opinion Fellow Talk

2016-2017 Fellow Talk Bloggers

June 30, 2016

Advertisement

Large Meta-analysis Supports Radial as Default Approach in All CAD Types

Increased Consumption of Subsidized Foods Ups Cardiometabolic Risk

Arizona patient will receive first U.S.-approved fully dissolving heart stent

欧盟更快速核准医疗器械导致更多的安全警告和产品召回

Timing and Type of Events Post-PCI Have Implications for Prognosis—and Honest Discussions With Patients

TAVR 可用于治疗二尖瓣主动脉瓣狭窄，但与永久性起搏器植入率更高相关联

TAVR for Bicuspid Aortic Valve Stenosis Feasible, but Associated With Higher Rate of Permanent Pacemaker Implantation

Structured Exercise Program Can Help the Sedentary Elderly but Does Not Curb CV Events

Now You See It: FDA Approves Absorb Bioresorbable Scaffold

Medical Devices Approved More Quickly in EU Face More Safety Alerts and Recalls

Los Dispositivos Médicos Aprobados Más Rápidamente en la UE son Objeto de Más Alertas de Seguridad y Nuevas Inspecciones

La Intervención TAVR para el Manejo de la Estenosis de la Válvula Aórtica Bicúspide es Viable pero se asocia a un Índice Más Alto de Implantación de Marcapasos Permanente

Fellowships in Advanced Interventional and Structural Cardiology Need Structure, Planning, and Collaboration—Stat!

TCTMD’s Top 10 Most Popular Stories for June 2016

Un Panel Asesor de la FDA Recomienda por un Estrecho Margen una Indicación de Mortalidad por EAC para el Antidiabético Empagliflozina

Precious Time: Questionable Treatments Often Used at the End of Life

FDA 顾问小组小范围建议使用糖尿病药物 empagliflozin 来改善 CVD 死亡率

FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin

Deadly Deceleration? Annual Declines in US Cardiovascular Death Rate Start to Slow

2016-2017 Fellow Talk Bloggers

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content